Evidence map›Paper›PMID 32918166›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2021

Gastrointestinal symptoms and the acquisition of enteric pathogens in Hajj pilgrims: a 3-year prospective cohort study.

Van-Thuan Hoang, Thi-Loi Dao, Tran Duc Anh Ly, Doudou Sow, Khadidja Belhouchat, Kamel Larbi Chaht, Laetitia Ninove, Tassadit Drali, Saber Yezli, Badriah Alotaibi and 4 more

RetractedAbstract readRetracted Publication
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 4 countries.

Van-Thuan HoangAix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
Thi-Loi DaoAix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
Tran Duc Anh LyAix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
Doudou SowAix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
Khadidja BelhouchatAix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
Kamel Larbi ChahtAix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
Laetitia NinoveInstitut Hospitalo-Universitaire Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13385, Marseille Cedex 05, France.
Tassadit DraliAix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
Saber YezliThe Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia.
Badriah AlotaibiThe Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia.
Didier RaoultInstitut Hospitalo-Universitaire Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13385, Marseille Cedex 05, France.
Philippe ParolaAix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
Vincent Pommier de SantiAix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
Philippe GautretAix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France. philippe.gautret@club-internet.fr.ORCID http://orcid.org/0000-0002-1664-958X
Aix-Marseille Université · FRMinistry of Health · SAInserm · FR

Funding

Agence Nationale de la Recherche ANR-10-IAHU-03
6 · The paper itself

Abstract

The acquisition of enteric pathogens and risk factors for Hajj-associated diarrhea in Hajj pilgrims is poorly documented. Pilgrims from Marseille participating in the Hajj in 2016-2018 underwent successive systematic rectal swabbing before and after their travel. Carriage of the main enteric pathogens was assessed by real-time PCR. Baseline demographics, adherence to individual preventive measures, gastrointestinal symptoms, and treatments were recorded. A total of 376 pilgrims were included. The median age was 62.0 years. During the Hajj, 18.6% presented at least one gastrointestinal symptom, 13.8% had diarrhea, and 36.4% had acquired at least one enteric pathogen. Enteropathogenic Escherichia coli (EPEC) and Enteroaggregative E. coli (EAEC) were the pathogens most frequently acquired by pilgrims (17.6% and 14.4%, respectively). Being female was associated with increased frequency of gastrointestinal symptoms during the pilgrimage (aOR = 2.38, p = 0.004). Enterohemorrhagic Escherichia coli (EHEC) acquisition was associated with a four-fold higher risk of reporting at least one gastrointestinal symptom and diarrhea (aOR = 3.68 and p = 0.01 and aOR = 3.96 and p = 0.01, respectively). Pilgrims who suffered from diarrhea were more likely to wash their hands more often (aOR = 2.07, p = 0.03) and to be either overweight (aOR = 2.71, p = 0.03) or obese (aOR = 2.51, p = 0.05). Enteric bacteria such as E. coli that are frequently associated with traveler's diarrhea due to the consumption of contaminated food and drink were frequently found in pilgrims. Respecting strict measures regarding food and water quality during the Hajj and adherence to preventive measures such as good personal hygiene and environmental management will help reduce the burden of gastrointestinal infections at the event.

Indexed as

Gastrointestinal DiseasesTravel-Related IllnessAdultAgedAged, 80 and overDiarrheaEscherichia coliFemaleFranceHumansMaleMiddle AgedProspective StudiesReligionRisk FactorsSaudi ArabiaAcquisitionDiarrheaGastrointestinalHajjPilgrimsRisk factors

Identifiers

PMID32918166
OpenAlexW3086905789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.